ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
68.81
-0.70
(-1.01%)
Closed April 11 4:00PM
68.81
0.00
( 0.00% )
Pre Market: 6:14AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
68.81
Bid
66.53
Ask
74.74
Volume
-
0.00 Day's Range 0.00
51.79 52 Week Range 89.91
Market Cap
Previous Close
68.81
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,093,119
Shares Outstanding
157,191,685
Dividend Yield
0.47%
PE Ratio
37.92
Earnings Per Share (EPS)
1.81
Revenue
1.14B
Net Profit
285.26M

About Bio Techne Corporation

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Minneapolis, Minnesota, USA
Founded
1970
Bio Techne Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TECH. The last closing price for Bio Techne was $68.81. Over the last year, Bio Techne shares have traded in a share price range of $ 51.79 to $ 89.91.

Bio Techne currently has 157,191,685 shares outstanding. The market capitalization of Bio Techne is $10.82 billion. Bio Techne has a price to earnings ratio (PE ratio) of 37.92.

TECH Latest News

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS PR Newswire MINNEAPOLIS, April 10, 2024 MINNEAPOLIS, April 10, 2024 /PRNewswire/...

BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY

BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY PR Newswire MINNEAPOLIS, April 8, 2024 Advanced Cell Diagnostics (ACD) achieves significant global customer...

BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE

BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE PR Newswire MINNEAPOLIS, April 3, 2024 MINNEAPOLIS, April 3, 2024 /PRNewswire/ -- Bio-Techne...

BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS

BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS PR Newswire MINNEAPOLIS, April 1, 2024 MINNEAPOLIS, April 1, 2024 /PRNewswire/ -- Bio-Techne...

BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES

BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES PR Newswire MINNEAPOLIS, March 28, 2024 MINNEAPOLIS, March 28, 2024 /PRNewswire/...

BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA

BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA PR Newswire MINNEAPOLIS, March 22, 2024 The QuantideX® qPCR BCR-ABL IS Kit is now compliant...

BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM

BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM PR Newswire MINNEAPOLIS, March 12, 2024 MINNEAPOLIS, March 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.792.6708445240267.0271.2766.74103570968.9878214CS
4-1.3-1.8542290686170.1172.8766.74104450869.92740254CS
12-1.43-2.0358769931770.2478.74564.965109311970.90596164CS
26-0.48-0.69274065521769.2978.74551.79115526467.83874904CS
52-10.02-12.710896866778.8389.9151.79105028573.12560498CS
156-32.9525-32.3817712812101.7625135.962551.7960594081.0003611CS
26018.13535.786877158450.675135.962538.792543479777.95569206CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PXMDPaxMedica Inc
$ 0.7571
(83.83%)
2.4M
ALLRAllarity Therapeutics Inc
$ 3.66
(59.34%)
1.91M
PASGPassage Bio Inc
$ 1.84
(35.29%)
67
ZPTAZapata Computing Holdings Inc
$ 3.38
(35.20%)
4.36M
NXPLNextPlat Corporation
$ 2.01
(34.00%)
1.17M
MOTSMotus GI Holdings Inc
$ 0.2717
(-35.72%)
35.99k
ASLNASLAN Pharmaceuticals Ltd
$ 0.4325
(-19.91%)
11
SPECSpectaire Holdings Inc
$ 0.5487
(-16.99%)
396
MGRMMonogram Orthopaedics Inc
$ 3.515
(-13.64%)
74.3k
BRNSBarinthus Biotherapeutics PLC
$ 2.92
(-12.31%)
10
ZPTAZapata Computing Holdings Inc
$ 3.38
(35.20%)
4.36M
PXMDPaxMedica Inc
$ 0.7571
(83.83%)
2.4M
BENFBeneficient
$ 0.0879
(27.21%)
2.29M
NKLANikola Corporation
$ 0.7399
(3.19%)
1.99M
ALLRAllarity Therapeutics Inc
$ 3.66
(59.34%)
1.91M

TECH Discussion

View Posts
LordTurkeyBaster LordTurkeyBaster 2 years ago
Top Meme Stock Mentions Money to Move 01/03/2022

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 2 years ago
Top Meme Stock Mentions Money to Move 10/15/2021

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 2 years ago
Top Meme Stock Mentions Money to Move 10/14/2021

$TECH: $1B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
TREND1 TREND1 9 years ago
NO REASON.
👍️0
getarealjob getarealjob 9 years ago
No worries, just read a blurb on a new diet drug that sounds pretty promising from these guys. Fexaramine, from these guys, looking at clinicals in 2-3 years.

Is there a reason you're no longer following it or just got tired and needed more time with others?
👍️0
TREND1 TREND1 9 years ago
NO longer follow TECH.
SORRY
👍️0
getarealjob getarealjob 9 years ago
Hey Trend, saw you over on AAL. This guy just popped up on my radar, obviously nothing going on in the board. What are your thoughts on this, if you have any beyond your charts? Not sure if you're on this one or not.
👍️0
TREND1 TREND1 9 years ago
TECH D
👍️0

Your Recent History

Delayed Upgrade Clock